ArticleScientific reports2024
Advancing frontline early pancreatic cancer detection using within-class feature extraction in FTIR spectroscopy.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-efficacy and affordable hyperspectral pancreatic tissue image analysis using near-infrared spectroscopy.Journal of pathology informatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study introduces a novel approach for the early detection of pancreatic cancer through biofluid spectroscopy, leveraging a unique machine learning pipeline comprising class-specific principal component analysis (PCA), linear discriminant analysis (LDA), and support vector machine (SVM) in both real patient and synthetic data. By conducting separate PCA on cancerous and non-cancerous samples and integrating the projections prior to LDA and SVM classification, we demonstrate significantly improved diagnostic accuracy compared to traditional methods. This methodology not only enhances predictive performance but also offers deeper insights into the influence of molecular spectra on model efficacy. Our findings, validated on real patient data, suggest a promising avenue for developing non-invasive, accurate diagnostic tools for early-stage pancreatic cancer detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.